Skip to main content

PEAK6 LLC

Position in NVO — Novo Nordisk A S

CIK 1389958 AUSTIN, TX

Position in NVO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$0
-$5,758,541 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
7 quarters on record

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Derivatives in NVO

reported options exposure · as of Jun 30, 2026
CallValue
$28,457,184
CallShares
593,600
PutValue
$5,139,168
PutShares
107,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

PEAK6 LLC holds $5,014,937 across 4 Drug Manufacturers - General names.

# Ticker Company Shares Value (USD) Open

All Filings in NVO

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,457,184 593,600
2026-06-30 $5,139,168 107,200
2026-03-31 $23,655,975 643,700
2026-03-31 $5,758,541 156,695
2026-03-31 $5,453,700 148,400
2025-12-31 $5,520,480 108,500
2025-12-31 $72,096,960 1,417,000
2025-12-31 $8,062,546 158,462
2025-09-30 $70,894,024 1,277,600
2025-09-30 $8,131,837 146,546
2025-09-30 $8,378,990 151,000
2025-06-30 $8,917,384 129,200
2025-06-30 $7,010,361 101,570
2025-06-30 $19,132,344 277,200
2025-03-31 $40,386,304 581,600
2025-03-31 $17,831,011 256,783
2025-03-31 $7,930,048 114,200
2024-12-31 $8,602 100
2024-12-31 $13,343,938 155,126
2024-12-31 $34,330,582 399,100